PS

Priya Singh

Active Director Director DIN 09569759
DIN 09569759 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Priya Singh

Data last updated:

Priya Singh is a Director at Gng Biotech Private Limited (since 2022). The company operates in Chemicals. Gng Biotech Private Limited reported revenue of ₹29.2 Lakh (FY 2024).

DIN 09569759
Primary Designation Director
Industry Chemicals
First Appointment 12 Apr 2022
Oldest Company Age 4 yrs
Largest company Gng Biotech Private Limited · ₹29.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gng Biotech Private Limited U24290MH2022PTC380418
Director12 Apr 20222022₹29.2 Lakh (FY 2024)Active

Board colleagues of Priya Singh

NameDINCompanyDesignation
Praveen Kumar Singh09569758Gng Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gng Biotech Private Limited
Premium access

Shareholding and investment profile for Priya Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priya Singh

Priya Singh currently holds 1 directorship: Gng Biotech Private Limited (Director, since 12 Apr 2022, revenue ₹29.2 Lakh (FY 2024)).

Priya Singh was first appointed on 12 Apr 2022 as Director at Gng Biotech Private Limited.

The current boards of Priya Singh's companies include Praveen Kumar Singh (Gng Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available